Exploring honey-derived compounds as potential inhibitors of NDRG1 for breast cancer treatment under hypoxic conditions: a multiomics profiling, molecular docking, and molecular dynamics study
Abstract Background Hypoxia has been recognized as a major contributor to cancer progression. Targeting hypoxia-derived factors, particularly in breast cancer, may present an auspicious strategy for cancer therapy. Honey-derived natural products have demonstrated therapeutic potential for various ai...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SpringerOpen
2025-10-01
|
| Sarja: | Future Journal of Pharmaceutical Sciences |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s43094-025-00854-y |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|